Mobile Gamma Cameras Market - Forecast(2024 - 2030)
Mobile Gamma Cameras Market Overview
Report Coverage
The
report: “Mobile Gamma
Cameras Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of
the following segments of the Mobile Gamma Cameras Market.
By
Type: Single
head, Double head, and Triple head.
By
Application:
Thyroid scanning, Organ imaging (heart, kidney, lungs, liver, and others),
Renal imaging, Cardiac imaging, Breast imaging, and others.
By
End User: Hospitals,
Imaging Facilities, Cancer treatment centers, ASCs, and others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).
Key Takeaways
- Geographically, the North America Mobile Gamma Cameras Market accounted for the highest revenue share in 2021. The growth is owing to the across-the-board presence of diagnostic facilities and high health consciousness among people. Nevertheless, Asia-Pacific is poised to dominate the market over the period 2022-2027.
- Mounting adoption of such technologies across the globe, proliferating breakthroughs in advanced imaging procedures, and surging chronic maladies are the factors said to be preeminent drivers driving the growth of the Mobile Gamma Cameras Market. Health complications accompanied by scintillation cameras are said to reduce market growth.
- Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Mobile Gamma Cameras Market report.
Mobile Gamma Cameras Market Share, By Geography (%) in 2021
For more details on this report - Request for Sample
Mobile Gamma Cameras Market Segment Analysis-By Application
The
Mobile Gamma Cameras Market based on the application type can be further
segmented into thyroid scanning, organ imaging (heart, kidney, lungs, liver,
and others), renal imaging, breast imaging, and others. The organ imaging
segment held the largest share in 2021. The growth is owing to a massive surge
in organ compilations such as Sjogren’s syndrome, Hashimoto’s thyroiditis,
Diabetes, Autoimmune hepatitis, and many more. With the mounting pervasiveness
of such organ-associated illnesses, the overall mortality rate is on the rise.
As a result, the overall demand for gamma cameras has heightened owing to their
top-notch imaging expertise. Furthermore, organ imaging along with the breast
imaging segment is estimated to be the fastest-growing segment with a CAGR of
5.6% over the forecast period 2022-2027. This growth is owing to proliferating
incidences of breast cancer and cardiovascular ailments. Heart attacks are the
leading cause behind the death of millions of people all over the globe every
year. Thus, the demand for cardiac imaging is witnessing new heights year after
year. Correspondingly, breast complications have emerged as a severe headache
for women which is ultimately driving the growth.
Mobile Gamma Cameras Market Segment Analysis-By End-User
The Mobile Gamma Cameras Market based on the end-user basis can be further segmented into hospitals, imaging facilities, cancer treatment centers, ASCs, and others. The hospital segment held the largest share in 2021. The growth is owing to the fully furnished nature of hospitals. From top-flight medical practitioners to sophisticated tools and techniques, you name it you have it. As a result, patients feel more safe and comfortable undergoing in-hospital treatments. In addition to that, the growing emergence of private hospitals is another prominent factor providing various growth opportunities as private hospitals are known for their swift and hassle-free treatments. Moreover, hospitals along with the ambulatory surgical centers' segment are estimated to be the fastest-growing segment with a CAGR of 5.8% over the forecast period 2022-2027. This growth is owing to the rising cost of healthcare worldwide. Make no mistake hospitals are recognized for their quality treatments but they are too known for notorious hospital stays which eventually leads to humungous bills. Thus, as ASCs provide outpatient surgeries (same-day entry and exist), patients' preferences are growing and the demand for such facilities is predominating slightly.
Mobile Gamma Cameras
Market Segment Analysis-By Geography
The Mobile Gamma Cameras Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 39% of the overall market in 2021. The growth in this segment is owing to the factors such as dwindling immunities and enlarging prevalence of complications like obesity, diabetes, and cancer. Earlier when most of the work is used to get completed manually, today the picture has changed completely, especially in high-income countries like the US and Canada. Consequently, with prolonged sittings and vulnerable metabolism life-threatening compilations like heart attack and cancer have come to the foreground on an unprecedented scale. Furthermore, developed healthcare infrastructure, growing research activities attributed to a constant flow of hard cash, and the attentive public is the factors helping the aforementioned market to grow. However, Asia-Pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to ameliorating health infrastructure and research expertise as expanding economic affluence is making it possible for governments to allocate more funding. Also, enlarging old-age population is a major reason behind surging chronic ailments which has its fair share in the growth of the mobile gamma cameras market in the Asia-pacific region.
Mobile Gamma Cameras
Market Drivers
Proliferating organ complications is Anticipated to Boost Market Demand.
Growing Old-age population, disposable incomes, and research spending are Expected to Boost Market Demand.
Healthcare systems in contemporary society are finding it hard to cope with the ferocious surge of ailments. Thus, the situation will be a nightmare in the near future as the world's geriatric population is anticipated to reach 2 billion in upcoming years. Therefore, in view of the current situation governments have started allocating more riches to infrastructure development and research activities. For instance, Chinese healthcare infrastructure crossed the 7 trillion yuan mark in 2020. Similarly, US healthcare spending is anticipated to reach $6 trillion by the year 2028. Besides, with the growing GDP per capita incomes of many developing countries, it is becoming easy for people to undergo required treatments.
Mobile Gamma Cameras Market Challenges
Health hitches associated with anger cameras are Anticipated to Hamper Market Growth.
There are several health side effects associated with mobile gamma camera usage in imaging which instead of treating the ailments can result in severe health complications. High radiation exposures in a short span of time set complications like radiation syndrome in motion. Also, the heavyweight of cameras increases the risk of patients under observation or medical practitioners being crushed to death. On another hand, radioisotopes that are embedded in patients’ bodies may behave abnormally and lead to severe health problems. However, the increasing prevalence of heart attached may support market growth. As per CDC, in the U.S. around 805,000 people had a heart attack in 2019.
Mobile Gamma Cameras Industry Outlook:
Product
launches, mergers and acquisitions, joint ventures, and geographical expansions
are key strategies adopted by players in the aforementioned market. Mobile
gamma cameras market top 10 companies include-
- General
Healthcare
- Crystal
Photonics
- Adolesco
AB
- MiE
GmbH
- Gamma
Medica
- Dilon
technologies
- DDD-Diagnostic
- Spectrum
Dynamics Medical
- Beijing
Hamamatsu Photon Techniques Inc
- Digirad
Corporation
Recent Developments
- On May 6, 2021, Illinois, United States-based healthcare company “GE Healthcare”, well-known for being a subsidiary of General Electric announced that it has successfully acquired France-based molecular imaging company “Zionexa” which is famous for its in-vivo biomarkers. The transaction has added Cerianna (an imaging agent which is recently approved by the Food and Drug Administration).
- On April 2, 2020, Virginia, United States-based medical device company “Dilon technologies”, recognized for its breast cancer solutions, announced the successful acquisition of Georgia, United States-based medical device manufacturing company “Dune Medical.” The transaction has added FDA approved device MarginProbe to Dilon’s portfolio which will further help the company in breast cancer treatments.
- On September 10, 2019, California, United States-based company “Digirad Corporation”, a well-known firm famous for its diagnostic expertise announced the successful acquisition of Oakdale, California-based company “ATRM Holdings.” The transaction simply aimed at diversifying the revenue sources of Digirad.